Compare Enphase Energy Inc (ENPH) vs ResMed Inc. (RMD) Price & Performance
Price performance (Past 24H)
Key statistics
Key statistics
Enphase Energy Inc vs ResMed Inc. — how do they compare? Enphase Energy Inc trades at $42.52 (market cap $5.81B), while ResMed Inc. trades at $202.27 (market cap $28.80B). The key difference: ResMed Inc. is far larger — about 5× Enphase Energy Inc's market cap, and ResMed Inc. pays a 1.21% dividend while Enphase Energy Inc pays none. Which is the better fit depends on your goals.
| ENPH | RMD | |
|---|---|---|
Market Cap | $5.81B | $28.80B |
Sector | Technology | Health |
52-Week High | $72.33 | $293.73 |
52-Week Low | $26.12 | $182.82 |
Enterprise Value | $5.46B | $27.99B |
Dividend Yield | — | 1.21% |
Aura AI Summary
Signals from Pluang's Aura AI — not financial advice
Aura AI Summary
Signals from Pluang's Aura AI — not financial advice
Enphase Energy (ENPH) trades at $44.985, up 4.47% with a neutral technical signal despite bullish moving averages. The company has beaten earnings expectations for three consecutive quarters, though revenue declined from $2.3B in 2023 to $1.47B in 2025. Analyst sentiment is mixed with 40% buy ratings but a consensus price target of $42.79 below current levels. Recent news highlights product expansions in Europe and Australia alongside ongoing legal scrutiny.
ENPH faces near-term headwinds with declining revenue and compressed margins, but maintains strong profitability metrics and consistent earnings beats. Investment appeal hinges on international growth execution and potential regulatory tailwinds, balanced against competitive pressures and stock volatility. The current valuation at 43.61 P/E requires robust growth reinstatement to justify upside.
No Aura AI signal available yet.
Returns comparison
Trailing returns across standard periods
Returns comparison
Trailing returns across standard periods
Top news
Latest headlines on both assets
Top news
Latest headlines on both assets
About Enphase Energy Inc
Enphase Energy is a global energy technology company. The company delivers smart, easy-to-use solutions that manage solar generation, storage, and communication on one platform. The company's microinverter technology primarily serves the rooftop solar market and produces a fully integrated solar-plus-storage solution. Geographically, it derives a majority of revenue from the United States.
Read more on ENPH →About ResMed Inc.
ResMed is one of the largest respiratory care device companies globally, primarily developing and supplying flow generators, masks and accessories for the treatment of sleep apnea. Increasing diagnosis of sleep apnea combined with ageing populations and increasing prevalence of obesity is resulting in a structurally growing market. The company earns roughly two thirds of its revenue in the Americas and the balance across other regions dominated by Europe, Japan and Australia. Recent developments and acquisitions have focused on digital health as ResMed is aiming to differentiate itself through the provision of clinical data for use by the patient, medical care advisor and payer in the out-of-hospital setting.
Read more on RMD →
